Skip to content

Home Pregnancy Test Evaluation Study

Home Pregnancy Test Evaluation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03589534
Enrollment
250
Registered
2018-07-18
Start date
2018-06-06
Completion date
2018-08-13
Last updated
2018-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Testing

Brief summary

This study will evaluate consumer preference and consumer results from a number of commercially available home pregnancy tests. The study is being conducted as a formal assessment home pregnancy tests sold in Western Europe.

Detailed description

The study will be conducted in two parts: Part 1: Volunteers representative of pregnancy test users will use a range (4 of 7 different tests being evaluated) in their own home to gain usability data. All products will be used according to their instructions for use which, where required, will be translated into English prior to the study start. A study questionnaire will be completed after each test is used. Part 2: The volunteers will attend the study site soon after completing their last home test and be required to read randomised results of tests conducted by study technicians (pregnant and not pregnant) to gain an understanding of their ability to correctly read results of the tests. The technician will also read and record the test results to enable both the laboratory agreement (technician read) and the consumer readability to be determined and compared for each product. Each volunteer will be required to provide a urine sample for determining pregnancy status and quantitative urinary hormone measurement (this is done to confirm the result obtained at home using the HPTs). At the end of the testing period the volunteers will also be asked to rank the four products they have used in the study, based on a series of statements regarding usability and readability of the tests

Interventions

DIAGNOSTIC_TESThome pregnancy test

Each participant will use 4 different home pregnancy tests

Sponsors

SPD Development Company Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Aged 18-45 years * Willing to give informed consent * Willing to conduct a personal home pregnancy test and reveal their pregnancy status

Exclusion criteria

* Currently or previously employed by SPD, Alere, Unipath, P&G, Abbott, or affiliates * Has an immediate relative\* currently or previously employed by SPD, Alere, Unipath, P&G, Abbott or affiliates * Taken a hormonal preparation containing hCG in the last month, e.g. Pregnyl® * Recently miscarried and yet to have 2 complete menstrual cycles before study start

Design outcomes

Primary

MeasureTime frameDescription
3. Demonstration of consumer preference for a HPT1 week• The ranking of each Home Pregnancy Test in order of preference
1. Demonstration of volunteer preference for a HPTs.1 week• The cumulative scores on a 7-point likert scale for ease of use questions on the device usability at home questionnaire, where 1 equals very good and 7 equals very poor for each attribute.
2. Demonstration of volunteer readability of HPTs1 week• The cumulative scores on a 7-point likert scale for readability questions on the device readability at SPD questionnaire, where 1 equals very easy and 7 equals very difficult for each attribute.

Secondary

MeasureTime frameDescription
1. Accuracy of reading1 weekThe per cent agreement (accuracy) between the result read by the volunteer and true result for each standard tested (i.e 0 hCG will be not pregnant and 25mIU/ml hCG will be pregnant) for each Home pregnancy test evaluated.
Agreement of reading1 weekThe agreement between volunteer home pregnancy test results and those of a technician testing the same urine standard (volunteer vs. technician test result)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026